Cargando…
Treatment of pulmonary arterial hypertension: A review of drugs available for advanced therapy
Pulmonary hypertension (PH) has traditionally been considered a rare disease with a uniformly poor prognosis. However, this was prior to the introduction of advanced therapies for this condition, and more recent registries in the treatment era have shown 5-year survival rates of up to 65%. Prior to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
South African Medical Association
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279001/ https://www.ncbi.nlm.nih.gov/pubmed/34286246 http://dx.doi.org/10.7196/SARJ.2019.v25i1.236 |